In recent years, the fentanyl crisis has escalated dramatically in the United States, with over... (16 revisions)
On January 30, 2025, the FDA approved Vertex Pharmaceuticals' Journavx (suzetrigine) for... (22 revisions)
Recent data indicates a promising decline in drug overdose deaths across the United States, with... (26 revisions)